10X Genomics(TXG)
Focus: 10X Genomics is a public biotechnology company developing genomics and spatial biology platforms for research and diagnostics across oncology, neurology, and ophthalmology. They are a leading provider of single-cell and spatial analysis technologies with $619M in FY 2025 revenue.
Profile data last refreshed 52m ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
5+6 this month
Growing — net +6 jobs in 30d
41 jobs added vs 35 removed. Steady team buildout.
Should You Work at 10X Genomics?
AI assessment10X Genomics offers exposure to transformative genomics technology and strong revenue momentum, but recent layoffs and deepening losses warrant caution on job security and organizational stability.
Why Work Here
- Rapid revenue growth (20% YoY from FY 2024 to FY 2025) demonstrates strong market demand for their genomics platforms
- Recently launched Atera platform (April 2026) and secured Cleveland Clinic partnership for bladder cancer diagnostics, signaling active innovation and clinical validation
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$619M
Help build intelligence for 10X Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.